key: cord-1050153-dfury0sz authors: Simms, Emily Lauren; Chung, Hyunjae; Oberding, Lisa; Muruve, Daniel A.; McDonald, Braedon; Bromley, Amy; Pillai, Dylan R.; Chun, Justin title: Post‐mortem molecular investigations of SARS‐CoV‐2 in an unexpected death of a recent kidney transplant recipient date: 2021-03-15 journal: Am J Transplant DOI: 10.1111/ajt.16549 sha: 0986df114db26a01a249d5fda4f66e01bc9ca4f1 doc_id: 1050153 cord_uid: dfury0sz Solid organ transplant recipients are vulnerable to severe infection during induction therapy. We report a case of a 67‐year‐old male who died unexpectedly 10 days after receiving a kidney transplant on February 10, 2020. There was no clear cause of death, but COVID‐19 was considered retrospectively, as the death occurred shortly after the first confirmed case of COVID‐19 in Canada. We confirmed the presence of SARS‐CoV‐2 components in the renal allograft and native lung tissue using immunohistochemistry for SARS‐CoV‐2 spike protein and RNA scope in situ hybridization for SARS‐CoV‐2 RNA. Results were reaffirmed with the Food and Drug Administration Emergency Use Authorization approved Bio‐Rad SARS‐CoV‐2 digital droplet PCR for the kidney specimen. Our case highlights the importance of patient autopsies in an unfolding global pandemic and demonstrates the utility of molecular assays to diagnose SARS‐CoV‐2 post‐mortem. SARS‐CoV‐2 infection during induction therapy may portend a fatal clinical outcome. We also suggest COVID‐19 may be transmittable via renal transplant. Institute of Nutrition, Metabolism and Diabetes Solid organ transplant recipients are vulnerable to severe infection during induction therapy. We report a case of a 67-year-old male who died unexpectedly 10 days after receiving a kidney transplant on February 10, 2020. There was no clear cause of death, but COVID-19 was considered retrospectively, as the death occurred shortly after the first confirmed case of COVID-19 in Canada. We confirmed the presence of SARS-CoV-2 components in the renal allograft and native lung tissue using immunohistochemistry for SARS-CoV-2 spike protein and RNA scope in situ hybridization for SARS-CoV-2 RNA. Results were reaffirmed with the Food and Drug Administration Emergency Use Authorization approved Bio-Rad SARS-CoV-2 digital droplet PCR for the kidney specimen. Our case highlights the importance of patient autopsies in an unfolding global pandemic and demonstrates the utility of molecular assays to diagnose SARS-CoV-2 post-mortem. SARS-CoV-2 infection during induction therapy may portend a fatal clinical outcome. We also suggest COVID-19 may be transmittable via renal transplant. basic (laboratory) research/science, clinical research/practice, donors and donation: donorderived infections, infection and infectious agents-viral, kidney transplantation/nephrology, kidney transplantation: living donor, pathology/histopathology, patient safety clinical assay to detect SARS-CoV-2 with superior sensitivity despite low viral load previously used to detect COVID-19 RNA in RT-PCR negative samples. [5] [6] [7] [8] Here, we report the case of a patient who died unexpectedly 10 days following a living donor KTx. We use IHC, RNA scope, and ddPCR to establish the cause of death related to COVID-19 by confirming viral RNA and spike (S) protein presence in donor kidney tissue. A 67-year-old male with end stage kidney disease due to insulin- nonreactive for hepatitis C antibody, hepatitis D negative, and HIV negative. Medications included insulin, amlodipine, atorvastatin, hydroxyzine, irbesartan, terazosin, and metformin. There was no travel or COVID-19 exposure history. His immunosuppressive medications consisted of basilixumab, tacrolimus, and prednisone. On February 9, 2020, 9 days after his transplant and uneventful hospitalization, the patient was discharged with no concerns other than a mild elevation of monocytes (1.1 × 10 9 /L) ( Table 1) . His discharge medications included tacrolimus, mycophenolic acid, a prednisone taper, lamivudine, and trimethoprim/sulfamethoxazole (TMP/SMX). On the evening of February 9, 2020, less than 4 h after being discharged from the hospital, the patient experienced sudden onset dyspnea. Paramedics found him to be hypotensive with a widecomplex bradyarrhythmia. He became unresponsive with a peripheral capillary oxygen saturation 100% on 15 L/min via face mask. At hospital arrival, his heart rhythm was converted to a narrow-complex tachycardia with a heart rate of 130 beats per minute (BPM). 12-lead ECG showed atrial fibrillation with rapid ventricular response without ischemia. Multiple blood draws were required due to the presence of fibrin strand and platelet clumping. Laboratory blood tests showed elevated peripheral white blood cell count was 38.9 × 10 9 /L signal was observed in lung tissue, but lower than the clinically validated threshold. Using three methods of viral protein and/or RNA detection, we The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Data are available on request from the authors. Justin Chun https://orcid.org/0000-0002-3820-7192 Solid organ transplantation during the COVID-19 pandemic COVID-19 infection in solid organ transplant recipients: a single-center experience with patients immediately after transplantation Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient Multiorgan and renal tropism of SARS-CoV-2 Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients COVID-19 epidemiological and economic research data A systematic review of COVID-19 infection in kidney transplant recipients: a universal effort to preserve patients' lives and allografts COVID-19 and kidney transplantation: a systematic review Covid-19 and kidney transplantation COVID-19 in transplant recipients: the Spanish experience COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy Viral load of SARS-CoV-2 in clinical samples Viral dynamics in mild and severe cases of COVID-19 Kidney disease is associated with inhospital death of patients with COVID-19 Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19 Early changes in kidney transplant immunosuppression regimens during the COVID-19 pandemic IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)